logo

Iovance Biotherapeutics Inc (IOVA) Stock: A Year of Highs and Lows in the Market

CROX

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Iovance Biotherapeutics Inc’s current trading price is -69.72% away from its 52-week high, while its distance from the 52-week low is 9.90%. The stock’s price range over this period has fluctuated between $5.05 and $18.33. The company, operating within the financial sector, had a trading volume of approximately 8.41 million for the day, which was noticeably higher than the average daily share volume of 7.47 million over the last 3 months.

Iovance Biotherapeutics Inc experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $18.33 on 02/28/24, while the lowest price for the same period was registered at $5.05 on 02/11/25.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Iovance Biotherapeutics Inc (IOVA) has experienced a quarterly decline of -32.23% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.69B and boasts a workforce of 557 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 8.15, with a change in price of -4.06. Similarly, Iovance Biotherapeutics Inc recorded 7,157,727 in trading volume during the last 100 days, posting a change of -42.25%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for IOVA stands at 0.10. Similarly, the long-term debt-to-equity ratio is also 0.09.

IOVA Stock Stochastic Average

Today, Iovance Biotherapeutics Inc’s raw stochastic average for the past 50 days stands at 12.99%, indicating a decline from the raw stochastic average of the last 20 days, which was 34.48%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 41.15% and 41.00% respectively.

IOVA Stock Price Performance Analysis

A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The metric has seen a significant loss of -25.00% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -53.09%. Over the past 30 days, the price of IOVA has leaped by -10.34%. And in the last five days, it has fallen by -0.36%.

Most Popular